Skip to main content
Clinical Trials/DRKS00000329
DRKS00000329
Not yet recruiting
Not Applicable

Optimization of the medical diagnostics and therapy managing in colorectal tumors using F-18-Deoxyglucose (FDG) positron emission tomography (PET) and gene expression data (GenPET Colon-2008). - GenPET Colon

Deutsches Krebsforschungszentrum0 sites80 target enrollmentFebruary 19, 2010
ConditionsC18.0-C18.9

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C18.0-C18.9
Sponsor
Deutsches Krebsforschungszentrum
Enrollment
80
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 19, 2010
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Deutsches Krebsforschungszentrum

Eligibility Criteria

Inclusion Criteria

  • Patients with a histologically confirmed primary colorectal carcinoma

Exclusion Criteria

  • rejection of the examination by the patient
  • diabetes mellitus
  • acute psychosis and other diseases with limited possibilities to understand the examination
  • pregnant women
  • claustrophobic patients

Outcomes

Primary Outcomes

Not specified

Similar Trials